期刊文献+

不同病理类型的2型糖尿病肾病患者临床特征比较 被引量:2

Comparison of clinical features in type 2 diabetic patients with various lesions of diabetic nephropathy
原文传递
导出
摘要 目的回顾性分析并比较不同病理类型的2型糖尿病肾病患者的临床特征。方法1990年12月至2004年4月在我院肾脏病研究所住院并行肾穿刺活检的150例2型糖尿病肾病患者,其中弥漫性系膜硬化病变(DIF)患者73例,结节性肾小球硬化病变(NOD)患者77例。分析并比较以下指标:糖尿病病程,高血压病程,体重指数(BMI),眼底病变,HbA_lc,血浆白蛋白,血脂水平,24 h尿蛋白定量,N-乙酰- B-氨基葡萄糖苷酶(NAG),尿渗透压,肌酐清除率。结果(1)NOD组患者糖尿病病程较DIF组患者长[(122.0±8.1 vs56.0±7.8)个月,p<0.01],高血压病程较DIF组患者短[(49.0±10.3 vs 84.0±12.6)个月,p<0.05],BMI较DIF组患者低[(24.1±0.4 vs 26.1±0.4)kg/m^2,P<0.01],尿蛋白水平较DIF组高[(3.8±0.3 vs 1.9±0.2)g/24 h,P<0.01],肌酐清除率较DIF组患者低(45.2±3.1 vs 64.4±3.6) ml/min;(2)NOD组患者中,92%有糖尿病视网膜病变,显著高于DIF组的13%(P<0.01)。结论不同病理类型的糖尿病。肾病患者临床特征不同,NOD组患者的糖尿病病程更长,肾脏损害更明显,更容易出现糖尿病视网膜病变;DIF患者高血压病程更长,BMI更高。 Objective To retrospectively investigate and compare the clinical features in type 2 diabetic patients with various lesions of diabetic nephropathy. Methods One hundred and fifty patients of type 2 diabetes mellitus were registered from December 1990 to April 2004, among them 73 cases of diffuse glomerulosclerosis (DIF) and 77 nodular glomerulosclerosis (NOD) were all proven by renal biopsy. Data such as the durations of diabetes mellitus and hypertension, body mass index (BMI), diabetic retinopathy, HbAtc, plasma albumin, proteinuria, urine N-acetyl-β-glucosaminidase, urine osmolarity, creatinine clearance rate (Ccr) were collected and compared. Results ( 1 ) Compared with the patients with DIF, the patients with NOD had longer duration of diabetes mellitus [ ( 122.0 ± 8.1 vs 56.0 ± 7.8 ) months, P 〈 0. 01 ) ], shorter duration of hypertention [ ( 49.0 ± 10.3 vs 84.0±12.6)months, P〈0. 05], lower BMI [(24.1 ±0.4 vs 26.1 ±0.4)kg/m^2, P〈0. 01], more severe proteinuria [ ( 3.8 ±0. 3 vs 1.9 ± 0. 2 ) g/24 h, P 〈 0. 01 ], and lower Ccr (45.2 ± 3.1 vs 64.4 ± 3.6 ) ml/ rain. (2) In the patients with NOD and DIF, there were 92% and 13% cases accomparied by diabetic retinopathy respectively (P 〈0.01 ). Conclusion The patients with NOD had longer diabetic duration, more severe renal damage, and were more likely to develop diabetic retinopathy. The patients with DIF had longer duration of hypertension and higher BMI.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2007年第4期327-330,共4页 Chinese Journal of Endocrinology and Metabolism
关键词 糖尿病肾病 弥漫系膜硬化 结节性肾小球硬化 Diabetic nephropathies Diffuse glomerulosclerosis Nodular glomerulosclerosis
  • 相关文献

参考文献15

  • 1谌贻璞.糖尿病肾病的病理表现[J].中华老年多器官疾病杂志,2002,1(3):167-169. 被引量:5
  • 2Roger M, Nadia A. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol, 2003,14 : 1358-1373.
  • 3Heaf JG, Lokkegaard H, Larsen S. The relative prognosis of nodular and diffuse diabetic nephropathy. Scand J Urol Nephrol, 2001,35:233- 238.
  • 4陈惠萍,郑丰,胡章学,姚小丹,朱茂艳,曾彩虹,王建平,黎磊石.非胰岛素依赖性糖尿病肾病的临床病理分析[J].肾脏病与透析肾移植杂志,1998,7(2):118-122. 被引量:20
  • 5Yasuda T, Imai H, Nakamoto Y, et al. Significance of fibrils in the formation of Kirnmelstiel-Wilson nodule. Virchows Arch, 1992,421: 297-303.
  • 6Hosttter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int, 1981,19:410-415.
  • 7Kimmelstiel P, Wilson MB. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol, 1936,12:83-98.
  • 8Klein R, Klein BE, Moss SE, et al. The Wiscosin Epidemiologic Study of Diabetic Retinopathy. 4-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol, 1989,107:244-249.
  • 9Osterby R, Tapia J, Nyberg G, et al. Renal structures in type 2 diabetic patients with elevated albumin excretion rate. APMIS, 2001, 109:75-76.
  • 10Daila Vestra M, Sailer A, Bortoloso E, et al. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab, 2000, 26 (Suppl 4) :8-14.

二级参考文献14

  • 1[1]Vora JP, Chattington PD, Ibrahim H. Clinical Manifestation and Natural History of Diabetic Nephropathy. In:Johnson RJ , Feehally J, eds. Comprehensive Clinical Nephrology. London: Mosby, 2000.1-34.
  • 2[2]Parving HH, Φsterby R, Ritz E. Diabetic Nephropathy.In: Brenner BM, ed. The Kidney. Vol Ⅱ . 6th ed. Philadelphia: W.B. Saunders, 2000. 1731-1773.
  • 3[3]邹万忠,谌贻璞,章友康.肾活检病理诊断图鉴.北京:人民卫生出版社,1999.93-95.
  • 4[1]The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993,329: 977-986.
  • 5[2]UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998,325: 837-853.
  • 6[3]Ruilope LM, Luno J. Angiotensin blockade in type 2 diabetic renal disease. Kidney Int Suppl, 2002,82:61-63.
  • 7[4]Pahor M, Psaty BM, Alderman MH, et al. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care, 2000,23:888-892.
  • 8[5]Fried LF, Qrchard TJ, Kasiske BL, et al. Effect of lipid reduction on the progression of renal diseases: a meta-analysis. Kidney Int, 2001,59:260-269.
  • 9[8]Brenner BM, Cooper ME, de Zeeuw D, et al. Effect of losartan on renal and cardiovascular outcome in patients with type 2 diabetes and nephropathy. N Engl J Med,2001,345: 861-869.
  • 10[9]Parving HH, Lehnert H, Brochner-Mortensen J, et al.The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med,2001,345: 870-878.

共引文献68

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部